Left Bundle Branch Optimized Cardiac Resynchronization Therapy (Lot-Crt): Results From International Lbbap Collaborative Study Group

BACKGROUND Cardiac resynchronization therapy (CRT) based on the conventional biventricular pacing (BiV-CRT) technique sometimes results in broad QRS complex and suboptimal response. OBJECTIVE We aimed to assess the feasibility and outcomes of CRT based on left bundle branch area pacing (LBBAP, in lieu of the right ventricular lead) combined with coronary venous left ventricular pacing in an international multicenter study. METHODS LBBAP-optimized CRT (LOT-CRT) was attempted in nonconsecutive patients with CRT indications. Addition of the LBBA (or coronary venous) lead was at the discretion of the implanting physician, who was guided by suboptimal paced QRS complex, and/or on clinical grounds. RESULTS LOT-CRT was successful in 91 of 112 patients (81%). The baseline characteristics were as follows: mean age 70 +/- 11 years, female 22 (20%), left ventricular ejection fraction 28.7% +/- 9.8%, left ventricular end-diastolic diameter 62 +/- 9 mm, N-terminal pro-B-type natriuretic peptide level 5821 +/- 8193 pg/mL, left bundle branch block 47 (42%), nonspecific intraventricular conduction delay 25 (22%), right ventricular pacing 26 (23%), and right bundle branch block 14 (12%). The procedure characteristics were as follows: mean fluoroscopy time 27.3 +/- 22 minutes, LBBAP capture threshold 0.8 +/- 0.5 V @ 0.5 ms, and R-wave amplitude 10 mV. LOT-CRT resulted in significantly greater narrowing of QRS complex from 182 +/- 25 ms at baseline to 144 +/- 22 ms (P < .0001) than did BiV-CRT (170 +/- 30 ms; P < .0001) and LBBAP (162 +/- 23 ms; P < .0001). At follow-up of >= 3 months, the ejection fraction improved to 37% +/- 12%, left ventricular end-diastolic diameter decreased to 59 +/- 9 mm, N-terminal pro-B-type natriuretic peptide level decreased to 2514 +/- 3537 pg/mL, pacing parameters were stable, and clinical improvement was noted in 76% of patients (New York Heart Association class 2.9 vs 1.9). CONCLUSION LOT-CRT is feasible and safe and provides greater electrical resynchronization as compared with BiV-CRT and could be an alternative, especially when only suboptimal electrical re synchronization is obtained with BiV-CRT. Randomized controlled trials comparing LOT-CRT and BiV-CRT are needed.